Emergency physicians' adherence to Center for Disease Control and Prevention guidance during the 2009 influenza A H1N1 pandemic

Western Journal of Emergency Medicine

Volumn 14, Issue 2, 2013, Pages 191-199

  Hsieh, Yu Hsiang ^a   Kelen, Gabor D ^a   Dugas, Andrea F ^a   Chen, Kuan Fu ^a,b,c   Rothman, Richard E ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

^c CHANG GUNG UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

AZITHROMYCIN; CEFEPIME; CEFTRIAXONE; COTRIMOXAZOLE; METRONIDAZOLE; MOXIFLOXACIN; OSELTAMIVIR; PENICILLIN DERIVATIVE; PIPERACILLIN PLUS TAZOBACTAM; VANCOMYCIN;

ADULT; ANTIBIOTIC THERAPY; ANTIVIRAL THERAPY; ARTICLE; CENTER FOR DISEASE CONTROL AND PREVENTION GUIDANCE; COMMUNITY ACQUIRED PNEUMONIA; EMERGENCY PHYSICIAN; FEMALE; HEALTH SERVICE; HIGH RISK PATIENT; HOSPITAL ADMISSION; HUMAN; INFLUENZA A (H1N1); INFLUENZA A RAPID TEST; MAJOR CLINICAL STUDY; MALE; PANDEMIC; PRACTICE GUIDELINE; PUBLIC HEALTH SERVICE; SEASONAL INFLUENZA;

EID: 84879069212     PISSN: 1936900X     EISSN: 19369018     Source Type: Journal    
DOI: 10.5811/westjem.2012.11.12246     Document Type: Article

References (29)

1. Novel Swine-Origin Influenza A (H1N1) Virus Investigation Team, Dawood F, Jain S, et al. Emergence of a novel swine-origin influenza A (H1N1) virus in humans. N Engl J Med 2009;360:2605-2615.
2. CDC Estimates of 2009 H1N1 Influenza Cases, Hospitalizations and Deaths in the United States, April - December 12, 2009., 2010. Available at http://www.cdc.gov/h1n1flu/estimates-2009-h1n1.htm. Accessed January 18, 2010.
3. Dawood F, Iuliano A, Reed C, et al. Estimated global mortality associated with the first 12 months of 2009 pandemic influenza A H1N1 virus circulation: a modelling study. Lancet Infect Dis 2012;12:687-695.
4. Olson D, Heffernan R, Paladini M, et al. Monitoring the impact of influenza by age: emergency department fever and respiratory complaint surveillance in New York City. PLos Med 2007;4:e247.
5. Hsieh Y, Chen K, Gaydos C, et al. Antiviral Prescriptions to US Ambulatory Care Visits with a Diagnosis of Influenza Before and After High Level of Adamantane Resistance 2005-06 Season. PLoS One 2010;5:e8945.
6. Weingarten S, Friedlander M, Rascon D, et al. Influenza surveillance in an acute-care hospital. Arch Intern Med 1988;148:113-116. (Pubitemid 18071386)
7. Rothman R, Hsieh Y, Yang S. Communicable respiratory threats in the ED: tuberculosis, influenza, SARS, and other aerosolized infections. Emerg Med Clin North Am 2006;24:989-1017. (Pubitemid 44376820)
8. The 2009 H1N1 Pandemic: Summary Highlights, April 2009-April 2010. Rep. Centers for Disease Control and Prevention. Available at: http://www.cdc.gov/ h1n1flu/cdcresponse.htm. Accessed August 27, 2012.
9. FAQ's for Emergency Departments in Epidemic or Pandemic Influenza Outbreaks. American College of Emergency Physicians, 2009. Available at: http://www.acep.org/practres.aspx?LinkIdentifier=id&id=45423&fid= 908&Mo=No. Accessed November 9, 2009.
10. National Strategic Plan for Emergency Department Management of Outbreaks of Novel H1N1 Influenza. American College of Emergency Physicians, 2009. Available at http://www.acep.org/WorkArea/DownloadAsset.aspx?id=45781. Accessed November 9, 2009.
11. Interim Guidance on Infection Control Measures for 2009 H1N1 Influenza in Healthcare Settings, Including Protection of Healthcare Personnel. Centers for Disease Control and Prevention (CDC), 2009. Available at http://www.cdc.gov/ h1n1flu/guidelines-infection-control.htm. Accessed Febuary 4, 2010.
12. Interim Guidance on Infection Control Measures for 2009 H1N1 Influenza in Healthcare Settings, Including Protection of Healthcare Personnelage. Rep. Centers for Disease Control and Prevention, Available at: www.cdc.gov/h1n1flu/ guidelines-infection-control.htm. Accessed Febuary 4, 2010.
13. Updated Interim Recommendations for the Use of Antiviral Medications in the Treatment and Prevention of Influenza for the 2009-2010 Season. Centers for Disease Control and Prevention (CDC), 2009. Available at: www.cdc.gov/h1n1flu/ recommendations. htm. Accessed Februay 4, 2010.
14. CDC Health Alert Network (HAN) Info Service Message: CDC Guidance on Antiviral Treatment of Patients with Confirmed, Probable, or Suspected Cases of Novel Influenza A (H1N1). 2009. Available at: http://www.cdc.gov/h1n1flu/HAN/ 052709.htm. Accessed February 4, 2010.
15. CDC Health Alert Network (HAN) Info Service Message: Recommendations for Early Empiric Antiviral Treatment in Persons with Suspected Influenza who are at Increased Risk of Developing Severe Disease. Centers for Disease Control and Prevention (CDC), Available at http://www.cdc.gov/H1N1flu/HAN/101909.htm. Accessed February 4, 2010.
16. Interim Recommendations for Clinical Use of Influenza Diagnostic Tests During the 2009-10 Influenza Season. Centers for Disease Control and Prevention (CDC), 2009. Available at: http://www.cdc.gov/flu/weekly/weeklyarchives2008- 2009/08-09summary.htm. Accessed February 4, 2010.
17. Gilboy N, Tanabe P, Travers D, et al. Emergency Severity Index, Version 4: Implementation Handbook. Agency for Healthcare Research and Quality 2005;4.
18. Pollock N, Duong S, Cheng A, et al. Ruling out novel H1N1 influenza virus infection with direct fluorescent antigen testing. Clin Infect Dis 2009;49:e66-68.
19. Drexler J, Helmer A, Kirberg H, et al. Poor clinical sensitivity of rapid antigen test for influenza A pandemic (H1N1) 2009 virus. Emerg Infect Dis 2009;15:1662-1664.
20. Tang J, Tambyah P, Lai F, et al. Differing symptom patterns in early pandemic vs seasonal influenza infections. Arch Intern Med 2010;170:861-867.
21. Shiley K, Nadolski G, Mickus T, et al. Differences in the epidemiological characteristics and clinical outcomes of pandemic (H1N1) 2009 influenza, compared with seasonal influenza. Infect Control Hosp Epidemiol 2010;31:676-682.
22. Thompson D, Jungk J, Hancock E, et al. Risk Factors for 2009 Pandemic Influenza A (H1N1)-Related Hospitalization and Death Among Racial/Ethnic Groups in New Mexico. Am J Public Health 2011;101:1776-1784.
23. Donaldson L, Rutter P, Ellis B, et al. Mortality from pandemic A/H1N1 2009 influenza in England: public health surveillance study. BMJ 2009;339:b5213.
24. May L, Lung D, Harter K. An intervention to improve compliance with transmission precautions for influenza in the emergency department: successes and challenges. J Emerg Med 2010;42:79-85.
25. Vanderweil S, Pelletier A, Hamedani A, et al. Declining antibiotic prescriptions for upper respiratory infections, 1993-2004. Acad Emerg Med 2007;14:366-369. (Pubitemid 46464024)
26. Gonzales R, Camargo CJ, MacKenzie T, et al. Antibiotic treatment of acute respiratory infections in acute care settings. Acad Emerg Med 2006;13:288-294.
27. Aspinall S, Good C, Metlay J, et al. Antibiotic prescribing for presumed nonbacterial acute respiratory tract infections. Am J Emerg Med 2009;27:544-551.
28. Ong S, Nakase J, Moran G, et al. Antibiotic use for emergency department patients with upper respiratory infections: prescribing practices, patient expectations, and patient satisfaction. Ann Emerg Med 2007;50:213-220. (Pubitemid 47259242)
29. Linder J, Bates D, Platt R. Antivirals and antibiotics for influenza in the United States, 1995-2002. Pharmacoepidemiol Drug Saf 2005;14:531-536. (Pubitemid 41179481)